BACKGROUND: Barriers to randomised clinical trial (RCT) recruitment include failure to identify eligible patients, reluctance of staff to approach them and attitudes of some health-care professionals and patients. As part of a larger UK prospective study examining the communication and involvement in RCTs of 22 multidisciplinary teams in Wales, we also assessed the attitudes of patients they treat towards trials. METHODS: Out of 1146 patients attending outpatient departments who were approached, 1146 (93%) completed the seven-item Attitudes to Randomised Trials Questionnaire (ARTQ), probing their general attitudes towards medical research and likely participation in a hypothetical two-arm RCT. RESULTS: Randomisation initially deterred ...
The attitudes of women patients with cancer were explored when they were invited to participate in o...
The attitudes of women patients with cancer were explored when they were invited to participate in o...
Background: Patient accrual into cancer clinical trials remains at low levels. This survey elicited...
BACKGROUND: Barriers to randomised clinical trial (RCT) recruitment include failure to identify eli...
Background:Barriers to randomised clinical trial (RCT) recruitment include failure to identify eligi...
BACKGROUND: barriers to randomised clinical trial (RCT) recruitment include failure to identify elig...
Background: Recruitment of patients into randomised clinical trials (RCTs) is essential for treatmen...
Background: Recruitment of patients into randomised clinical trials (RCTs) is essential for treatmen...
Background: Recruitment of patients into randomised clinical trials (RCTs) is essential for treatmen...
Background: Recruitment of patients into randomised clinical trials (RCTs) is essential for treatmen...
Objective: To explore how patients' treatment preferences were expressed and justified during recrui...
Cancer clinical trials (CCTs) are critical to translation and development of better therapies to imp...
OBJECTIVE: To explore how patients' treatment preferences were expressed and justified during recrui...
OBJECTIVE: To explore how patients' treatment preferences were expressed and justified during recrui...
Background: Patient accrual into cancer clinical trials remains at low levels. This survey elicited...
The attitudes of women patients with cancer were explored when they were invited to participate in o...
The attitudes of women patients with cancer were explored when they were invited to participate in o...
Background: Patient accrual into cancer clinical trials remains at low levels. This survey elicited...
BACKGROUND: Barriers to randomised clinical trial (RCT) recruitment include failure to identify eli...
Background:Barriers to randomised clinical trial (RCT) recruitment include failure to identify eligi...
BACKGROUND: barriers to randomised clinical trial (RCT) recruitment include failure to identify elig...
Background: Recruitment of patients into randomised clinical trials (RCTs) is essential for treatmen...
Background: Recruitment of patients into randomised clinical trials (RCTs) is essential for treatmen...
Background: Recruitment of patients into randomised clinical trials (RCTs) is essential for treatmen...
Background: Recruitment of patients into randomised clinical trials (RCTs) is essential for treatmen...
Objective: To explore how patients' treatment preferences were expressed and justified during recrui...
Cancer clinical trials (CCTs) are critical to translation and development of better therapies to imp...
OBJECTIVE: To explore how patients' treatment preferences were expressed and justified during recrui...
OBJECTIVE: To explore how patients' treatment preferences were expressed and justified during recrui...
Background: Patient accrual into cancer clinical trials remains at low levels. This survey elicited...
The attitudes of women patients with cancer were explored when they were invited to participate in o...
The attitudes of women patients with cancer were explored when they were invited to participate in o...
Background: Patient accrual into cancer clinical trials remains at low levels. This survey elicited...